Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation

Free Radical Biology and Medicine

Volumn 40, Issue 9, 2006, Pages 1494-1501

  Gaut, Joseph P ^a   Belaaouaj, Abderrazzaq ^b   Byun, Jaeman ^c   Roberts II, L Jackson ^d   Maeda, Nobuyo ^e   Frei, Balz ^f   Heinecke, Jay W ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b HÔPITAL MAISON BLANCHE   (France)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f OREGON STATE UNIVERSITY   (United States)

Author keywords

Chlorotyrosine; Free radicals; Lipid peroxidation; Myeloperoxidase; NADPH oxidase; Nitrotyrosine; Oxidative stress; Superoxide

Indexed keywords

AMINO ACID; ASCORBIC ACID; FREE RADICAL; GULONOLACTONE OXIDASE; ISOPROSTANE DERIVATIVE; LIPID; PERITONEAL DIALYSIS FLUID;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; HOST RESISTANCE; INFLAMMATION; KLEBSIELLA PNEUMONIAE; LIPID OXIDATION; MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYNTHESIS;

AMINO ACIDS; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; INFLAMMATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; L-GULONOLACTONE OXIDASE; LIPID PEROXIDATION; MICE; MICE, KNOCKOUT; OXIDATION-REDUCTION; SEPSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); GULO; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 33646022817     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.12.013     Document Type: Article

References (46)

1. Hampton M., Kettle A., and Winterbourn C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92 (1998) 3007-3017
2. Hazen S.L., Hsu F.F., Crowley J.R., Mueller D.M., and Heinecke J.W. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98 (1996) 1283-1289
3. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391 (1998) 393-397
4. Gaut J.P., Yeh G.C., Tran H.D., Byun J., Henderson J.P., Richter G.M., Brennan M.-L., Lusis A.J., Belaaouaj A., Hotchkiss R.S., and Heinecke J.W. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc. Natl. Acad. Sci. USA 98 (2001) 11961-11966
5. Gaut J.P., Byun J., Tran H.D., Lauber W.M., Carroll J.A., Hotchkiss R.S., Belaaouaj A., and Heinecke J.W. Myeloperoxidase produces nitrating oxidants in vivo. J. Clin. Invest. 109 (2002) 1311-1319
6. Bhattacharjee S., Pennathur S., Byun J., Crowley J., Mueller D., Gischler J., Hotchkiss R.S., and Heinecke J.W. The NADPH oxidase of neutrophils elevates o, o′-dityrosine crosslinks in proteins and urine during inflammation. Arch. Biochem. Biophys. 395 (2001) 69-77
7. Daugherty A., Dunn J.L., Rateri D.L., and Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest 94 (1994) 437-444
8. Heinecke J.W., Li W., Daehnke III H.L., and Goldstein J.A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268 (1993) 4069-4077
9. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., and Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272 (1997) 1433-1436
10. Hazen S.L., and Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99 (1997) 2075-2081
11. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., and Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272 (1997) 3520-3526
12. Padayatty S.J., Katz A., Wang Y., Eck P., Kwon O., Lee J.H., Chen S., Corpe C., Dutta A., Dutta S.K., and Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J. Am. Coll. Nutr. 22 (2003) 18-35
13. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic. Biol. Med. 28 (2000) 1421-1429
14. Carr A.C., McCall M.R., and Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb. Vasc. Biol. 20 (2000) 1716-1723
15. Frei B., England L., and Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 86 (1989) 6377-6381
16. Maeda N., Hagihara H., Nakata Y., Hiller S., Wilder J., and Reddick R. Aortic wall damage in mice unable to synthesize ascorbic acid. Proc. Natl. Acad. Sci. USA 97 2 (2000) 841-846
17. Hirche T.O., Gaut J.P., Heinecke J.W., and Belaaouaj A. Myeloperoxidase Plays Critical Roles in Killing Klebsiella pneumoniae and Inactivating Neutrophil Elastase: Effects on Host Defense. J. Immunol. 174 (2005) 1557-1565
18. Babior B.M., Curnutte J.T., and McMurrich B.J. The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. J. Clin. Invest. 58 (1976) 989-996
19. Heinecke J.W., Hsu F.F., Crowley J.R., Hazen S.L., Leeuwenburgh C., Mueller D.M., Rasmussen J.E., and Turk J. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Methods Enzymol. 300 (1999) 124-144
20. Morrow J.D., and Roberts L.J. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol. 300 (1998) 3-12
21. Frost M.T., Halliwell B., and Moore K.P. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem. J. 345 (2000) 453-458
22. Gaut J.P., Byun J., Tran H.D., and Heinecke J.W. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography electrospray ionization tandem mass spectrometry. Anal. Biochem. 300 (2002) 252-259
23. Babior B.M., Lambeth J.D., and Nauseef W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397 (2002) 342-344
24. Savenkova M.I., Mueller D.M., and Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269 (1994) 20394-20400
25. Podrez E.A., Schmitt D., Hoff H.F., and Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103 (1999) 1547-1560
26. Roberts L.J., and Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28 (2000) 505-513
27. Paterson D.L. Serious infections caused by enteric gram-negative bacilli- mechanisms of antibiotic resistance and implications for therapy of gram-negative sepsis in the transplanted patient. Semin. Respir. Infect. 17 (2002) 260-264
28. Li S., Taylor K.B., Kelly S.J., and Jedrzejas M.J. Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase. J. Biol. Chem. 276 (2001) 15125-15130
29. Botzki A., Rigden D.J., Braun S., Nukui M., Salmen S., Hoechstetter J., Bernhardt G., Dove S., Jedrzejas M.J., and Buschauer A. L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor: X-ray structure and molecular modeling of enzyme-inhibitor complexes. J. Biol. Chem. 279 (2004) 45990-45997
30. Long C.L., Maull K.I., Krishnan R.S., Laws H.L., Geiger J.W., Borghesi L., Franks W., Lawson T.C., and Sauberlich H.E. Ascorbic acid dynamics in the seriously ill and injured. J. Surg. Res. 109 (2003) 144-148
31. Schorah C.J., Downing C., Piripitsi A., Gallivan L., Al-Hazaa A.H., Sanderson M.J., and Bodenham A. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am. J. Clin. Nutr. 63 (1996) 760-765
32. Hill G.L., Blackett R.L., Pickford I., Burkinshaw L., Young G.A., Warren J.V., Schorah C.J., and Morgan D.B. Malnutrition in surgical patients. An unrecognised problem. Lancet 26 (1977) 689-692
33. Nathens A.B., Neff M.J., Jurkovich G.J., Klotz P., Farver K., Ruzinski J.T., Radella F., Garcia I., and Maier R.V. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann. Surg. 236 6 (2002) 814-822
34. Armour J., Tyml K., Lidington D., and Wilson J.X. Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J. Appl. Physiol. 90 (2001) 795-803
35. Campbell J.D., Cole M., Bunditrutavorn B., and Vella A.T. Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis. Cell Immunol. 194 (1999) 1-5
36. Hotchkiss R.S., Dunne W.M., Swanson P.E., Davis C.G., Tinsley K.W., Chang K.C., Buchman T.G., and Karl I.E. Role of apoptosis in Pseudomonas aeruginosa pneumonia. Science 294 (2001) 1783
37. Gokce N., Keaney Jr. J.F., Frei B., Holbrook M., Olesiak M., Zachariah B.J., Leeuwenburgh C., Heinecke J.W., and Vita J.A. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99 25 (1999) 3234-3240
38. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88 (1991) 1785-1792
39. Diaz M.N., Frei B., Vita J.A., and Keaney J.F. Antioxidants and atherosclerotic heart disease. N. Eng. J. Med. 337 (1997) 408-416
40. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., and Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361 (2003) 2017-2023
41. Reilly M., Delanty N., Lawson J.A., and FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94 (1996) 19-25
42. Chen K., Suh J., Carr A.C., Morrow J.D., Zeind J., and Frei B. Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1406-E1412
43. Levine M., Wang Y., Padayatty S.J., and Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc. Natl. Acad. Sci. USA 98 (2001) 9842-9846
44. Meagher E.A., Barry O.P., Lawson J.A., Rokach J., and FitzGerald G.A. Effects of vitamin E on lipid peroxidation in healthy persons. J. Am. Med. Assoc. 285 (2001) 1178-1182
45. Terasawa Y., Ladha Z., Leonard S.W., Morrow J.D., Newland D., Sanan D., Packer L., Traber M.G., and Farese Jr. R.V. Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E. Proc. Natl. Acad. Sci. USA 97 (2000) 13830-13834
46. Vainio H. Chemoprevention of cancer: lessons to be learned from beta-carotene trials. Toxicol. Lett. 112-113 (2000) 513-517